Study for Efficacy and Dose Escalation of AD313 + Atomoxetine (SEED)
Condition: Obstructive Sleep Apnea Interventions: Drug: Dosing 1: Atomoxetine; Drug: Dosing 2-4: AD313 Sponsor: Apnimed Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2021 Category: Research Source Type: clinical trials
Measuring Atomoxetine and Aroxybutinin In Patients With OSA
Condition: Obstructive Sleep Apnea (OSA) Interventions: Drug: AD109 (atomoxetine/aroxybutynin); Drug: Atomoxetine Hydrochloride; Drug: Placebo Sponsor: Apnimed Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 25, 2021 Category: Research Source Type: clinical trials